[Bacterial meningitis: pathophysiology and therapy 1991].
The new concepts of pathogenesis and pathophysiology of purulent meningitis are discussed and evaluated in logical sequence. Possible therapeutic down-modulation of the initial burst of inflammatory responses, especially with steroids (dexamethasone), is critically analyzed. Prompt and adequate antibiotic therapy remains the essential measure in the management of patients with bacterial meningitis. The individual aspects of antimicrobial therapy are described and specific recommendations are made.
Schaad
U B
UB
Medizinische Universitäts-Kinderklinik Bern.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002555:Cerebrospinal Fluid / Q000382:microbiology; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology*; D009092:Mucous Membrane / Q000382:microbiology
D000900:Anti-Bacterial Agents; D003907:Dexamethasone
Bakterielle Meningitis: Pathophysiologie und Therapie 1991.